Biomarkers for Predicting the Response to Radiation-Based Neoadjuvant Therapy in Rectal Cancer

被引:7
作者
Chen, Yuhong [1 ]
Yang, Biao [2 ]
Chen, Mingyang [3 ]
Li, Zhaojun [4 ]
Liao, Zhengyin [1 ]
机构
[1] Sichuan Univ, West China Hosp, West China Med Sch, Dept Abodominal Oncol, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, West China Med Sch, Dept Gastroentol, Chengdu 610041, Sichuan, Peoples R China
[3] Sichuan Univ, West China Stomatol Hosp, Chengdu 610041, Sichuan, Peoples R China
[4] Hainan Med Univ, Hainan Affiliated Hosp, Hainan Gen Hosp, Dept Radiat Oncol, Haikou 570311, Hainan, Peoples R China
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2022年 / 27卷 / 07期
关键词
rectal cancer; biomarker; neoadjuvant chemoradiation; response; PATHOLOGICAL COMPLETE RESPONSE; PREOPERATIVE CHEMORADIATION THERAPY; HUMAN COLORECTAL-CANCER; COPY NUMBER ALTERATIONS; TUMOR RESPONSE; CHEMORADIOTHERAPY RESPONSE; MOLECULAR MARKERS; TEXTURE ANALYSIS; PROGNOSTIC VALUE; DNA METHYLATION;
D O I
10.31083/j.fbl2707201
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Locally advanced rectal cancer (RC) is treated with neoadjuvant chemoradiotherapy (nCRT) followed by radical surgery. Currently, organ-sparing approaches and/or "watch-and-wait" strategies other than unnecessary surgery have been suggested as the best option for patients who achieve complete regression after neoadjuvant treatment. However, patients respond differently to nCRT, hence the urgent need for effective methods to predict whether individual rectal cancer patients could benefit from this treatment. In this review, we summarize the biomarkers reported to be potential predictors of the therapeutic response of RC to nCRT. Biomarkers that are associated with genes, ribonucleic acid (RNA) and proteins are summarized and described first, followed by other types including immune and tumour microenvironment-related biomarkers, imaging biomarkers, microbiome-associated biomarkers, and blood-based biomarkers.
引用
收藏
页数:26
相关论文
共 163 条
[1]   T-cell complexity and density are associated with sensitivity to neoadjuvant chemoradiotherapy in patients with rectal cancer [J].
Akiyoshi, Takashi ;
Gotoh, Osamu ;
Tanaka, Norio ;
Kiyotani, Kazuma ;
Yamamoto, Noriko ;
Ueno, Masashi ;
Fukunaga, Yosuke ;
Mori, Seiichi .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (02) :509-518
[2]   Natural killer-like signature observed post therapy in locally advanced rectal cancer is a determinant of pathological response and improved survival [J].
Alderdice, Matthew ;
Dunne, Philip D. ;
Cole, Aidan J. ;
O'Reilly, Paul G. ;
McArt, Darragh G. ;
Bingham, Vicky ;
Fuchs, Marc-Aurel ;
McQuaid, Stephen ;
Loughrey, Maurice B. ;
Murray, Graeme I. ;
Samuel, Leslie M. ;
Lawler, Mark ;
Wilson, Richard H. ;
Salto-Tellez, Manuel ;
Coyle, Vicky M. .
MODERN PATHOLOGY, 2017, 30 (09) :1287-1298
[3]   Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer [J].
Anitei, Maria-Gabriela ;
Zeitoun, Guy ;
Mlecnik, Bernhard ;
Marliot, Florence ;
Haicheur, Nacilla ;
Todosi, Ana-Maria ;
Kirilovsky, Amos ;
Lagorce, Christine ;
Bindea, Gabriela ;
Ferariu, Dan ;
Danciu, Mihai ;
Bruneval, Patrick ;
Scripcariu, Viorel ;
Chevallier, Jean-Marc ;
Zinzindohoue, Franck ;
Berger, Anne ;
Galon, Jerome ;
Pages, Franck .
CLINICAL CANCER RESEARCH, 2014, 20 (07) :1891-1899
[4]   18F-FDG PET/CT Is an Early Predictor of Pathologic Tumor Response and Survival After Preoperative Radiochemotherapy with Bevacizumab in High-Risk Locally Advanced Rectal Cancer [J].
Avallone, Antonio ;
Aloj, Luigi ;
Pecori, Biagio ;
Caraco, Corradina ;
De Stefano, Alfonso ;
Tatangelo, Fabiana ;
Silvestro, Lucrezia ;
Granata, Vincenza ;
Bianco, Francesco ;
Romano, Carmela ;
Di Gennaro, Francesca ;
Budillon, Alfredo ;
Petrillo, Antonella ;
Muto, Paolo ;
Botti, Gerardo ;
Delrio, Paolo ;
Lastoria, Secondo .
JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (11) :1560-1568
[5]   High expression of microRNA-199a-5p is associated with superior clinical outcomes in patients with locally advanced rectal cancer [J].
Baek, Dong Won ;
Kim, Gyeonghwa ;
Kang, Byung Woog ;
Kim, Hye Jin ;
Park, Su Yeon ;
Park, Jun Seok ;
Choi, Gyu-Seog ;
Kang, Min Kyu ;
Hur, Keun ;
Kim, Jong Gwang .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (01) :105-115
[6]   Sex Differences and Tumor Blood Flow from Dynamic Susceptibility Contrast MRI Are Associated with Treatment Response after Chemoradiation and Long-term Survival in Rectal Cancer [J].
Bakke, Kine M. ;
Meltzer, Sebastian ;
Grovik, Endre ;
Negard, Anne ;
Holmedal, Stein H. ;
Gjesdal, Kjell-Inge ;
Bjornerud, Atle ;
Ree, Anne H. ;
Redalen, Kathrine R. .
RADIOLOGY, 2020, 297 (02) :352-360
[7]   Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy [J].
Becker, K ;
Mueller, JD ;
Schulmacher, C ;
Ott, K ;
Fink, U ;
Busch, R ;
Böttcher, K ;
Siewert, JR ;
Höfler, H .
CANCER, 2003, 98 (07) :1521-1530
[8]   Circulating Biomarkers for Response Prediction of Rectal Cancer to Neoadjuvant Chemoradiotherapy [J].
Bedin, Chiara ;
Crotti, Sara ;
D'Angelo, Edoardo ;
D'Aronco, Sara ;
Pucciarelli, Salvatore ;
Agostini, Marco .
CURRENT MEDICINAL CHEMISTRY, 2020, 27 (25) :4274-4294
[9]   Elevated platelet count is a negative predictive and prognostic marker in locally advanced rectal cancer undergoing neoadjuvant chemoradiation: a retrospective multi-institutional study on 965 patients [J].
Belluco, Claudio ;
Forlin, Marco ;
Delrio, Paolo ;
Rega, Daniela ;
Degiuli, Maurizio ;
Sofia, Silvia ;
Olivieri, Matteo ;
Pucciarelli, Salvatore ;
Zuin, Matteo ;
De Manzoni, Giovanni ;
Di Leo, Alberto ;
Scabini, Stefano ;
Zorcolo, Luigi ;
Restivo, Angelo .
BMC CANCER, 2018, 18
[10]   Lincp21-RNA as Predictive Response Marker for Preoperative Chemoradiotherapy in Rectal Cancer [J].
Benitez, Jose Carlos ;
Campayo, Marc ;
Diaz, Tania ;
Ferrer, Carme ;
Acosta-Plasencia, Melissa ;
Monzo, Mariano ;
Cirera, Luis ;
Besse, Benjamin ;
Navarro, Alfons .
JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (05)